公司资料
Lisata Therapeutics 股价、新闻与催化剂
- 股票代码:
- LSTA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.08 USD (-0.92%)
收盘价
最后更新: 2026年8月17日
31.7M USD
市值
股价为何变动
As of Aug 17, 2026, LSTA closed down 0.92% at $1.08. No new same-company headline was identified in the current news window.
公司概览
业务概览
Lisata Therapeutics is a precision oncology company focused on therapies designed to improve tumor penetration and enhance drug delivery into solid tumors. Its story is built around the idea that better access to tumors can improve the performance of other anti-cancer approaches.
所在地与行业分类
Lisata is headquartered in the United States and listed on NASDAQ, with a small-cap oncology biotechnology profile. It sits in the development-stage cancer and drug-delivery segment.
商业模式特征
The company depends on clinical data, partnership potential, and the ability to prove that its platform can improve outcomes in solid tumors. Investors generally watch trial updates, strategic collaborations, and capital needs.
生物医药行业定位
Lisata occupies a specialized precision-oncology niche within biotech. The stock is driven by the market's view of whether its delivery-focused strategy can create meaningful clinical differentiation.
未来催化剂
- Lisata’s catalysts are certepetide and the pancreatic-cancer / solid-tumor development path, where the next update matters a lot. The company still needs stronger clinical proof.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。